| Literature DB >> 26972733 |
Manabu Fujimoto1, Yoshihide Asano2, Takayuki Ishii1, Fumihide Ogawa3, Tamihiro Kawakami4, Masanari Kodera5, Masatoshi Abe6, Taiki Isei7, Takaaki Ito8, Yuji Inoue9, Shinichi Imafuku10, Ryokichi Irisawa11, Masaki Ohtsuka12, Mikio Ohtsuka13, Takafumi Kadono2, Masakazu Kawaguchi14, Ryuichi Kukino15, Takeshi Kono16, Keisuke Sakai17, Masakazu Takahara18, Miki Tanioka19, Takeshi Nakanishi20, Yasuhiro Nakamura21, Akira Hashimoto22, Minoru Hasegawa1, Masahiro Hayashi14, Hiroshi Fujiwara23, Takeo Maekawa24, Koma Matsuo25, Naoki Madokoro26, Osamu Yamasaki12, Yuichiro Yoshino27, Andres Le Pavoux28, Takao Tachibana29, Hironobu Ihn9.
Abstract
The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS.Entities:
Keywords: antiphospholipid antibody syndrome; dermatomyositis; rheumatoid arthritis; systemic lupus erythematosus; vasculitis
Mesh：
Substances：
Year: 2016 PMID： 26972733 DOI： 10.1111/1346-8138.13275
Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005